TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

The aim of this study was to evaluate associations between TP53 status and outcomes after transarterial embolization (TAE) for the treatment of patients with hepatocellular carcinoma (HCC). This single-institution study included patients from 1/2014 to 6/2022 who underwent TAE of HCC and genomic ana...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ken Zhao, Anita Karimi, Luke Kelly, Elena Petre, Brett Marinelli, Erica S. Alexander, Vlasios S. Sotirchos, Joseph P. Erinjeri, Anne Covey, Constantinos T. Sofocleous, James J. Harding, William Jarnagin, Carlie Sigel, Efsevia Vakiani, Etay Ziv, Hooman Yarmohammadi
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Current Oncology
Subjects:	hepatocellular carcinoma interventional oncology transarterial embolization tumor protein p53
Online Access:	https://www.mdpi.com/1718-7729/32/1/51
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Multiple acute complications of transarterial chemoembolization of liver metastases
by: R. N. Abu Shamsia, et al.
Published: (2024-12-01)

Clinical Outcome of Superselective Transarterial Embolization for Acute Colonic Gastrointestinal Bleeding: A Retrospective Single-Center Experience
by: Rajendra Kumar Behera, et al.

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI)
by: Hai-Dong Zhu, et al.
Published: (2024-12-01)

Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
by: Su-Rong Pan, et al.
Published: (2024-11-01)

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01)

Idarubicin-loaded drug-eluting microspheres transarterial chemoembolization for intermediate stage hepatocellular carcinoma: safety, efficacy, and pharmacokinetics
by: Korsic Spela, et al.
Published: (2024-10-01)

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
by: Qinxue Sun, et al.
Published: (2025-01-01)

A bibliometric analysis of 30 years of research on transarterial radioembolization (TARE) for hepatocellular carcinoma
by: Tongyao Hu, et al.
Published: (2025-01-01)

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
by: Zhang G, et al.
Published: (2025-01-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Risk Factors for Postoperative Nausea and Vomiting After TACE: A Prospective Cohort Study
by: Yuzhu Wang, et al.
Published: (2024-12-01)

Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
by: Hongjie Cai, et al.
Published: (2025-02-01)

For Better or Worse
by: Sinenhlanhla Sithulisiwe Chisale
Published: (2016-07-01)

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
by: Wu L, et al.
Published: (2025-01-01)

The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors
by: Huang X, et al.
Published: (2025-01-01)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
by: Vlasios S. Sotirchos, et al.
Published: (2014-01-01)

The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
by: Wu Y, et al.
Published: (2025-02-01)

Kin Competition Drives the Evolution of Earlier Metamorphosis
by: Bing Dong, et al.
Published: (2025-01-01)

Immune Checkpoint Blockade in Melanoma – Earlier is Better?
by: Vincas Urbonas, et al.
Published: (2024-09-01)

Percutaneous transhepatic arterial access for coil embolization of hepatic artery infusion pump-associated bleeding
by: Anuj K. Dutta, et al.
Published: (2025-01-01)

Preoperative chemotherapy usage experience for intrahepatic cholangiocarcinoma
by: A. N. Polyakov, et al.
Published: (2023-03-01)

Earlier Intervention with Deep Brain Stimulation for Parkinson’s Disease
by: Gerson Suarez-Cedeno, et al.
Published: (2017-01-01)

For Better or Worse: The Effect of Prismatic Adaptation on Auditory Neglect
by: Isabel Tissieres, et al.
Published: (2017-01-01)

Vision of objects happens faster and earlier for location than for identity
by: Christian H. Poth, et al.
Published: (2025-02-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Case report: Transarterial chemoembolization for nasal hemangiosarcoma in a dog
by: Keunho Kim, et al.
Published: (2025-01-01)

COVID-19 – if the cure is worse than the disease. The Italian chaos
by: Giuseppe FERRARI
Published: (2020-03-01)

Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01)

DeweyTP: a labeling scheme for probabilistic XML data
by: Zi-yang CHEN, et al.
Published: (2013-11-01)

Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies
by: Augusto Magalhães, et al.
Published: (2021-01-01)

Women are worse off in developing and recovering from temporomandibular disorder symptoms
by: Anna Lövgren, et al.
Published: (2025-02-01)

Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpression
by: Steffen Markus Heckl, et al.
Published: (2025-01-01)

Prediction of Microcystis Blooms Based on TN:TP Ratio and Lake Origin
by: Yoshimasa Amano, et al.
Published: (2008-01-01)

TP2 COPPER TUBE OVERPRESSURE STRENGTHEN TECHNOLOGY AT ROOM TEMPERATURE
by: YANG Fan, et al.
Published: (2019-01-01)

Urban fruit bats give birth earlier in the season compared to rural fruit bats
by: Maya Weinberg, et al.
Published: (2025-01-01)

Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse
by: Maha Elsabaawy, et al.
Published: (2024-03-01)

A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Adriana Toro, et al.
Published: (2015-01-01)

Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival
by: Jana Wellhausen, et al.
Published: (2025-01-01)